Viewing nowCombinationOlmetin Tablet 20/10 Milligrams
Olmesartan Medoxomil 20mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.

MFDS item code 202003951 · Approved 2020.05.28 · Insurance code 671706550
Treatment of hypertension and hypercholesterolemia, and reduction of cardiovascular disease risk
This medication is used for patients who require simultaneous treatment with both Olmesartan Medoxomil and Rosuvastatin. Olmesartan Medoxomil is primarily used for the treatment of essential hypertension and plays a role in controlling blood pressure. Rosuvastatin helps improve lipid levels in patients with hypercholesterolemia and mixed dyslipidemia, which cannot be managed with diet and exercise alone. Additionally, Rosuvastatin is used as an adjunct therapy in patients with familial hypercholesterolemia and dysbetalipoproteinemia, lowering total cholesterol and LDL cholesterol, thereby slowing the progression of atherosclerosis. Furthermore, it is effective in reducing the risks of stroke, myocardial infarction, and vascular remodelling related to cardiovascular disease in high-risk patients. In summary, this medication is used to simultaneously manage hypertension and hyperlipidemia to reduce the risk of cardiovascular disease.
The recommended initial dose of Olmesartan Medoxomil is 10 mg once daily, regardless of meals. If blood pressure control is insufficient, the dosage may be increased to 20 mg once daily, and a maximum of 40 mg can be increased. Rosuvastatin can be administered at any time of day without regard to meals, with an initial dosage of 5 milligrams once daily. The maintenance dose is 10 milligrams once daily, and it may be adjusted at intervals of 4 weeks or longer to achieve better LDL cholesterol reduction.
Safety and efficacy in patients under 18 years of age have not been established, and therefore, administration is not performed.
This medication may cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Individuals allergic to this medication or its ingredients should not take it, nor should it be used by women who are potentially pregnant or breastfeeding. This medication is not suitable for patients with certain health conditions such as very poor kidney function, those undergoing dialysis, severe liver disease patients, or those with bile duct obstruction. Patients with muscular disorders or at high risk for muscle-related side effects should refrain from taking this medication or do so under caution. Patients at risk of a sudden drop in blood pressure, especially those with decreased body fluid or salt, should be closely monitored when starting this medication. Patients with kidney issues should have their kidney function and electrolyte levels regularly monitored through blood tests. This medication can enhance the blood pressure-lowering effect when taken with other antihypertensive medications, so caution is warranted. Additionally, this medication may affect liver function, so patients with a history of liver disease or heavy alcohol consumption should undergo periodic liver function tests. Symptoms like muscle pain or weakness should be reported to a doctor immediately, and in severe cases, discontinuation of the medication may be necessary. During the course of treatment, there is a risk of hyperkalemia (elevated potassium levels), so potassium levels should be monitored through blood tests. Caution should be exercised while driving or operating hazardous machinery, as side effects like dizziness may occur. There may be interactions with other medications during treatment, so if you are taking other medications, you must inform your doctor or pharmacist. Pregnant or breastfeeding women should not take this medication, and women who may become pregnant should use appropriate contraception. Safety and efficacy in children under 18 years of age have not been established, thus its use is not recommended. Elderly patients should be careful as the drug concentration in the body may increase. In case of overdose, symptoms such as hypotension and palpitations may occur; immediate consultation with a healthcare institution is necessary. This medication should be kept out of reach of children and should not be transferred to other containers.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, high fever with severe rash, blisters, skin peeling, pain in mouth/eye mucous membranes, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough + fever, yellowing of skin or eyes (jaundice), extreme drowsiness, sudden and severe headache, lightning-like headache, seizures, confusion, visual disturbances, paralysis, urine abnormalities.
Not everyone experiences these, and they can vary from person to person.
This medication can be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained between 1 degree and 30 degrees Celsius at room temperature. This will help safely retain the medication's efficacy.
White or pale yellow round film-coated tablets
30 tablets/box [30 tablets (10 tablets/Alu-Alu) × 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationOlmesartan Medoxomil 20mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd. Daewoong Pharmaceutical)
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Daewoong Pharmaceutical
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.